PFE Latest Headlines

Pfizer Adds New Early-Stage Heart Failure Candidate to Its China Pipeline

at www.tipranks.com (Fri, 6-Mar 11:32 AM)

Pharma giants pressed by Senate Democrats over Trump pricing deals

at seekingalpha.com (Fri, 6-Mar 10:45 AM)

Markets AM Need to Know: AI chip permits, Iran leadership, oil prices, and more

at seekingalpha.com (Fri, 6-Mar 6:25 AM)

Pfizer’s Weight-Loss Drug Approved in China — Up Against Generic Rivals

at www.tipranks.com (Fri, 6-Mar 2:37 AM)

China approves Pfizer’s GLP-1 drug for weight management, intensifying market competition

at seekingalpha.com (Fri, 6-Mar 2:27 AM)

Entera Bio Moves Toward Phase 3 With Oral Therapy That Could Transform Osteoporosis Treatment (NASDAQ: ENTX)

at www.tipranks.com (Thu, 5-Mar 9:00 AM)

Wells Fargo Sticks to Its Hold Rating for Pfizer (PFE)

at www.tipranks.com (Wed, 4-Mar 7:50 AM)

Pfizer Advances PF-07328948 Kidney Function Study, Supporting Long-Term Pipeline Value

at www.tipranks.com (Tue, 3-Mar 11:31 AM)

Pfizer-backed Priovant wins FDA priority review for lead asset

at seekingalpha.com (Tue, 3-Mar 7:24 AM)

PADCEV Plus Keytruda Shows Major Survival Benefit in Muscle-Invasive Bladder Cancer—A Potential Shift in Standard Care

Market Chameleon (Mon, 2-Mar 7:13 AM)

PPH, IHE, PJP: U.S. Pharmaceutical ETFs Offer Investors Innovation and Growth

at www.tipranks.com (Mon, 2-Mar 2:55 PM)

Positive Report for Pfizer (PFE) from Argus Research

at www.tipranks.com (Mon, 2-Mar 9:55 AM)

Pfizer Delivers Steady Growth Beyond COVID-19: 2025 Results Show 6% Revenue Increase in Core Portfolio and Strong Pipeline Momentum

Market Chameleon (Tue, 3-Feb 7:15 AM)

Pfizer Lowers 2026 Revenue Guidance But Reaffirms Profitability Targets Amid R&D Investment

Market Chameleon (Tue, 16-Dec 7:08 AM)

Pfizer Secures Global Rights to Oral GLP-1 Drug Candidate in $2 Billion Collaboration With Fosun Pharma

Market Chameleon (Tue, 9-Dec 7:09 AM)